(Q37327330)

19 August 2017

1 reference

title

Polycystic ovary syndrome: treatment strategies and management (English)

1 reference

polycystic ovary syndrome

19 August 2017

1 reference

1 reference

Héctor F Escobar-Morreale

series ordinal

1

1 reference

PubMed ID

19013863

19 August 2017

language of work or name

English

0 references

publication date

1 December 2008

1 reference

Expert Opinion on Pharmacotherapy

19 August 2017

1 reference

19 August 2017

9

1 reference

19 August 2017

17

1 reference

19 August 2017

2995-3008

1 reference

The prevalence and features of the polycystic ovary syndrome in an unselected population

19 August 2017

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Criteria for Defining Polycystic Ovary Syndrome as a Predominantly Hyperandrogenic Syndrome: An Androgen Excess Society Guideline

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

The molecular-genetic basis of functional hyperandrogenism and the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Human ovarian theca cells in culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Abdominal adiposity and the polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

The role of lifestyle modification in polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Sibutramine has a positive effect on clinical and metabolic parameters in obese patients with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Orlistat is as beneficial as metformin in the treatment of polycystic ovarian syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Effect of hypocaloric diet plus sibutramine treatment on hormonal and metabolic features in overweight and obese women with polycystic ovary syndrome: a randomized, 24-week study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Effect of sibutramine on weight reduction in women with polycystic ovary syndrome: a randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Cannabinoid-1 receptor blockade in cardiometabolic risk reduction: efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Bariatric surgery: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Metformin therapy in polycystic ovary syndrome reduces hyperinsulinemia, insulin resistance, hyperandrogenemia, and systolic blood pressure, while facilitating normal menses and pregnancy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Insulin-Lowering Agents in the Management of Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Decreases in ovarian cytochrome P450c17 alpha activity and serum free testosterone after reduction of insulin secretion in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Metformin or antiandrogen in the treatment of hirsutism in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Pregnancy loss, polycystic ovary syndrome, thrombophilia, hypofibrinolysis, enoxaparin, metformin

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Metformin reduces abortion in pregnant women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

A modern medical quandary: polycystic ovary syndrome, insulin resistance, and oral contraceptive pills

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Insulin-lowering drugs in polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

The androgenicity of progestins

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Effects of metformin and ethinyl estradiol-cyproterone acetate on lipid levels in obese and non-obese women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Serum uric acid concentration as non-classic cardiovascular risk factor in women with polycystic ovary syndrome: effect of treatment with ethinyl-estradiol plus cyproterone acetate versus metformin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Body iron stores are increased in overweight and obese women with polycystic ovary syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Pregnancy outcomes after bariatric surgery: maternal, fetal, and infant implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Obesity and the polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

Insulin-sensitizing agents in women with polycystic ovary syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14656560802559932

10.1517/14656560802559932

21 January 2018

Identifiers

DOI

1 reference

19 August 2017

1 reference

PubMed ID

19013863